MIM
FMTX

Monashee Investment Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Monashee Investment Management’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50,000
Closed -$1.75M – 476
2020
Q4 		$1.75M Buy
+50,000
New +$2.18M 0.23% 119

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Monashee Investment Management's FMTX Position: Q1 2021 in Review

Monashee Investment Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q1 2021, closing a stake of 50,000 shares — an estimated $1.75M sold.

Monashee Investment Management first reported a position in FMTX in Q4 2020 and held it in 1 quarter. The position peaked at $1.75M in Q4 2020. 87 funds tracked by Wall St. Rank hold FMTX as of Q1 2021.

  • Monashee Investment Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Monashee Investment Management sold 50,000 Forma Therapeutics Holdings, Inc. Common Stock shares in Q1 2021, an estimated $1.75M.
  • Monashee Investment Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Monashee Investment Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.75M in Q4 2020.
  • 87 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q1 2021.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.